• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EBR 0.25% 98.8¢

EBR SYSTEMS INC. - Charts / Financials

EBR Systems, Inc. is engaged in the treatment for patients suffering from cardiac rhythm... EBR Systems, Inc. is engaged in the treatment for patients suffering from cardiac rhythm diseases by providing physiological stimulation through endocardiac pacing. The Company is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The Company also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The Company operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 15.56pm 06/11/2024 (20 minute delay) ?
Day
Open $1.00   Day High $1.00   Day Low 97.5¢
Daily Volume 93182
Bids   Sellers
Number Price Volume   Number Price Volume
2 98.0¢ 9399   1 $1.00 43014

Directors & Senior Management

Mr. Allan Roger Will Executive Chairman of the Board
Mr. John Graham Mccutcheon President, Chief Executive Officer, Executive Director
Mr. Gary W. Doherty Chief Financial Officer
Mr. Michael Hendrickson Chief Operating Officer
Mr. Andrew Shute Senior Vice President - Global Field Operations
Mr. N. Parker Willis Chief Technology Officer
Ms. Madhuri Bhat Chief Regulatory Officer
Dr. Spencer H. Kubo Chief Medical Officer
Mr. Erik Strandberg Chief Commercial Officer
Mr. Brendan Case Company Secretary - Australia
Mr. Trevor John Moody Non-Executive Director
Mr. Christopher Dean Nave Non-Executive Director
Ms. Karen Ruth Drexler Non-Executive Independent Director
Dr. Bronwyn Louise Evans Non-Executive Independent Director
Dr. David Mark Steinhaus Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
98.8¢
Change
-0.003(0.25%)
Mkt cap ! $300.4M
Open High Low Value Volume
$1.00 $1.00 97.5¢ $91.97K 93.18K

Buyers (Bids)

No. Vol. Price($)
2 9399 98.0¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 43014 1
Last trade - 15.59pm 06/11/2024 (20 minute delay) ?
Last
99.0¢
  Change
-0.003 ( 1.54 %)
Open High Low Volume
99.5¢ 99.5¢ 97.5¢ 57105
Last updated 15.56pm 06/11/2024 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.